InvestorsHub Logo
Followers 33
Posts 1622
Boards Moderated 0
Alias Born 10/06/2015

Re: None

Monday, 02/21/2022 12:58:41 PM

Monday, February 21, 2022 12:58:41 PM

Post# of 20436
Considering Todos PASC (long haulers') trial is soon enlisting...I wonder if Todos is being encouraged to remove their "related products: Max and Daily," from availability.

CytoDyn got similar "helpful advice" from the FDA about allowing their drug "Leronlimab" to save lives by using EINDs. The theory was. It would interfere with trial enrollment.

Thus the life-saving EINDs stopped.

It looks like sales halt at month's end.

Understand, Tollovir potentially threatens the vaccination cash cow! The fewer people aware of Tollovid, its safety and efficacy... the better in BPs squinty little eyes.

Tollovid's availability up to now, has posed a possible problem/distraction/alternate response to Covid-19. This is NOT something bringing joy to BP.

Sorrowfully - Good-bye Tollovid!

IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOMDF News